SlideShare a Scribd company logo
1 of 31
PROJECT MANAGEMENT IN
PHARMACEUTICAL INDUSTRY
Prepared By: Guided By:
Chandani Tripathi Dr. Gayatri Patel
17MPHRA010 Associate Professor
1
2
Table of Content
• INTRODUCTION
• WHAT IS PLANNING?
• WHY PLANNING?
• TYPES OF PLANNING
• STEPS INVOLVED IN PLANNING
• ELEMENTS OF PLANNING
• CHALLENGES
3
• CONTROL AND IMPLEMENTATION
• PRE-REQUISITES FOR SUCCESSFUL PROJECT IMPLEMENTATION
• HOW DOES ONE MEASURES PROJECT SUCCESS
• CASE STUDY
• SUMMARY
• REFERENCES
4
INTRODUCTION
• Regulatory policies and compliances -----for new drug -------tighter,
impacting product development, and registration strategies.
• The pharmaceutical industry is under pressure to accelerate the drug-
development stage to compensate for the longer wait for regulatory
approval. As a result the companies are working on new products in parallel-
-----this leads to further hurdles in management of the product at once.
• Wourms B. Pharmaceutical Organizations Discover New Way to Stay Ahead of the Game: Project Management Outsourc. Pharm Process [Internet]. 2003;(16–18).
5
The Pharmaceutical Industry
6
WHAT IS PLANNING?
• Analyzing the current situation
• Assessing needs
• Establishing goals
• Setting objectives & targets
• Determining the strategies & responsibilities
• Resources
• Pharmaceutical Project Management- Tony Kennedy. Published by Marcel Dekkar, inc., New York Pg no. 57-64.
7
Why should one go for planning?
To clearly identify goals
To assess current needs and problems
To ensure wise use of available human and financial resources
To obtain additional resources
To provide a basis for evaluating effectiveness
To align staff priorities and build a sense of teamwork
Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15.
8
What are the types of planning ?
WORK PLANNING
Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15.
9
Process Program planning
Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15.
10
QA Dept.
Pharmaceutical Management-Sachin Itkar. Published by Nirali Prakashan Pg no. 3.1-3.2 & 15.1-15.7 11
Warehouse Dept.
Pharmaceutical Management-Sachin Itkar. Published by Nirali Prakashan Pg no. 3.1-3.2 & 15.1-15.7 12
Pharmaceutical Management-Sachin Itkar. Published by Nirali Prakashan Pg no. 3.1-3.2 & 15.1-15.7 13
Supply chain Management
Pharmaceutical Management-Sachin Itkar. Published by Nirali Prakashan Pg no. 3.1-3.2 & 15.1-15.7 14
Steps Involvedin Planning the Process
Define the target.
Prepare a list of necessary work packages
(studies).
Determine the logical sequence and estimate
durations.
Determine the critical path.
15
Steps Involvedin Planning the Process
Optimize the plan to reduce critical path length.
Plan resources and costs and adjust for
resource and budget constraints and priorities.
Adjust plan during execution to new data, as
required.
Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15.
16
Elements of
Planning
Functions
Objectives
Policies
Procedure
RulesPrograms
Budgets
Strategies
Projects
Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15.
17
Challenges
Scope
Planning,
execution,
and
monitoring
Timeline
and budget
planning
compliance
strategies
Risk
management
Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15.
18
Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15.
19
PROJECT IMPLEMENTATION
Adequate
Formulation
Proper
implementation
planning
Advance action
Timely
availability of
funds
Judicious
equipment
tendering and
procurement
Better contract
management
Effective
monitoring
mds3-ch38-planningmgmt-mar2012. 20
21
Project Success?
Project
Effectiveness
Project
Efficiency
Users
Interest
Product
Quality
22
Portfolio P, Systems M. Project Portfolio Management in the Pharmaceutical Industry Do Pharmaceutical Companies benefit financially from Project Portfolio
Management Systems ? Fjóla Steingrímsdóttir Project Portfolio Management in the Pharmaceutical Industry. 23
24
Eli Lilly
Background: Founded in 1876 in Indianapolis, USA, by Colonel Eli Lilly.
• 1st to produce insulin in 1923 + human insulin using recombinant DNA.
• Lilly is also the world's largest manufacturer and distributor of psychiatric
medications.
• 9th world's biggest pharmaceutical company.
• Crisis/ Problem: The patent expiration for Prozac as it counts 20 % of the
company's overall revenue.------ drop in sales by 23% .
• Raja BH. Open Innovation in Pharmaceutical Industry : A case study of Eli Lilly Open Innovation in Pharmaceutical Industry : A case study of Eli Lilly. 2015;
25
• 2) Fine imposed for illegal marketing. (Zyprexa)
• 3) Distrust that turned out in more restriction for drug approvals.
SOLUTION:
1) Increase in R&D budget by 30%, ($2.2 billion), hiring 700 scientists.
2) The firm extended their areas from psychopharmacology to a larger fields like
Neuroscience, Oncology, Endocrinology, Cardiovascular etc.
3) The Office of Alliance Management, based on the idea of (I) Find it, (II) Get it,
(III) Create value.
26
27
28
• TBDDI is Lilly’s Tuberculosis drug discovery
• TB Drug Accelerator (TBDA)
• Open innovation drug discovery program
• Public-Private partnerships (PPP)
Result: Due to these collaborations and technology transfer/ Knowledge
exchange the company has successfully regained its lost position. The new
upcoming tools like Crowdsourcing and open source drug discovery being
implemented by these company make the Outsource Licensing initiatives
multilateral all over the world making the innovation network boundary more
porous.
Raja BH. Open Innovation in Pharmaceutical Industry : A case study of Eli Lilly Open Innovation in Pharmaceutical Industry : A case study of Eli Lilly. 2015;
29
References
Pharmaceutical Project Management- Tony Kennedy. Published by Marcel
Dekkar, inc., New York Pg no. 57-64.
Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private
Limited, Pg no. 21.9-21.15.
Pharmaceutical Management-Sachin Itkar. Published by Nirali Prakashan Pg no.
3.1-3.2 & 15.1-15.7
Portfolio P, Systems M. Project Portfolio Management in the Pharmaceutical
Industry Do Pharmaceutical Companies benefit financially from Project Portfolio
Management Systems ? Fjóla Steingrímsdóttir Project Portfolio Management in
the Pharmaceutical Industry.
mds3-ch38-planningmgmt-mar2012.
30
31

More Related Content

What's hot

Pharmaceutical Business Development Process Flow
Pharmaceutical Business Development Process FlowPharmaceutical Business Development Process Flow
Pharmaceutical Business Development Process FlowMuhammad Ali Jehangir
 
Cdsco- a regulatory overview
Cdsco- a regulatory overviewCdsco- a regulatory overview
Cdsco- a regulatory overviewVivekanandan S
 
Investigator's Brochure - The Road Map for Investigators
Investigator's Brochure - The Road Map for InvestigatorsInvestigator's Brochure - The Road Map for Investigators
Investigator's Brochure - The Road Map for InvestigatorsClinosolIndia
 
New drug approval ppt
New drug approval pptNew drug approval ppt
New drug approval pptPrasad Bhat
 
Regulatory Affairs.
Regulatory Affairs.Regulatory Affairs.
Regulatory Affairs.Naila Kanwal
 
Phases of clinical trials 1,2,3 &4
Phases of clinical trials 1,2,3 &4Phases of clinical trials 1,2,3 &4
Phases of clinical trials 1,2,3 &4lillibabu
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]Sagar Savale
 
Case studies on Technology Transfer
Case studies on Technology TransferCase studies on Technology Transfer
Case studies on Technology TransferRishabhMaurya21
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalRajashri Survase Ojha
 
Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptRegulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptsandeep bansal
 
Technology transfer
Technology transfer  Technology transfer
Technology transfer Subhankar Das
 
New Approach to Pharma R&D / PPM
New Approach to Pharma R&D / PPMNew Approach to Pharma R&D / PPM
New Approach to Pharma R&D / PPMKelvin Stott
 
Product registration procedure in USA
Product registration procedure in USAProduct registration procedure in USA
Product registration procedure in USAGuru Balaji .S
 
New drugs and Clinical Trials Rule in india 2019
New drugs and Clinical Trials Rule in india 2019New drugs and Clinical Trials Rule in india 2019
New drugs and Clinical Trials Rule in india 2019Arya V Devi
 
Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Bhaswat Chakraborty
 
Hatch waxman act and paragraph iv litigations
Hatch waxman act and paragraph iv litigationsHatch waxman act and paragraph iv litigations
Hatch waxman act and paragraph iv litigationsAnumulaSurendra
 
IND INDA ANDA Application
IND INDA ANDA ApplicationIND INDA ANDA Application
IND INDA ANDA ApplicationRoshan Bodhe
 

What's hot (20)

Pharmaceutical Business Development Process Flow
Pharmaceutical Business Development Process FlowPharmaceutical Business Development Process Flow
Pharmaceutical Business Development Process Flow
 
Cdsco- a regulatory overview
Cdsco- a regulatory overviewCdsco- a regulatory overview
Cdsco- a regulatory overview
 
Pharmaceutical Industry: The Challenges and the Opportunities
Pharmaceutical Industry: The Challenges and the OpportunitiesPharmaceutical Industry: The Challenges and the Opportunities
Pharmaceutical Industry: The Challenges and the Opportunities
 
Investigator's Brochure - The Road Map for Investigators
Investigator's Brochure - The Road Map for InvestigatorsInvestigator's Brochure - The Road Map for Investigators
Investigator's Brochure - The Road Map for Investigators
 
New drug approval ppt
New drug approval pptNew drug approval ppt
New drug approval ppt
 
Regulatory Affairs.
Regulatory Affairs.Regulatory Affairs.
Regulatory Affairs.
 
Phases of clinical trials 1,2,3 &4
Phases of clinical trials 1,2,3 &4Phases of clinical trials 1,2,3 &4
Phases of clinical trials 1,2,3 &4
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]
 
505 (b) (2)
505 (b) (2)505 (b) (2)
505 (b) (2)
 
DMF -Drug Master File
DMF -Drug Master File DMF -Drug Master File
DMF -Drug Master File
 
Case studies on Technology Transfer
Case studies on Technology TransferCase studies on Technology Transfer
Case studies on Technology Transfer
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
 
Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptRegulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan ppt
 
Technology transfer
Technology transfer  Technology transfer
Technology transfer
 
New Approach to Pharma R&D / PPM
New Approach to Pharma R&D / PPMNew Approach to Pharma R&D / PPM
New Approach to Pharma R&D / PPM
 
Product registration procedure in USA
Product registration procedure in USAProduct registration procedure in USA
Product registration procedure in USA
 
New drugs and Clinical Trials Rule in india 2019
New drugs and Clinical Trials Rule in india 2019New drugs and Clinical Trials Rule in india 2019
New drugs and Clinical Trials Rule in india 2019
 
Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018
 
Hatch waxman act and paragraph iv litigations
Hatch waxman act and paragraph iv litigationsHatch waxman act and paragraph iv litigations
Hatch waxman act and paragraph iv litigations
 
IND INDA ANDA Application
IND INDA ANDA ApplicationIND INDA ANDA Application
IND INDA ANDA Application
 

Similar to Project management

Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...
Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...
Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...ReportsnReports
 
Presentation for UMass Workshop
Presentation for UMass WorkshopPresentation for UMass Workshop
Presentation for UMass WorkshopDaisy LaFlamme
 
Critical Path Initiative Challenges
Critical  Path  Initiative  ChallengesCritical  Path  Initiative  Challenges
Critical Path Initiative ChallengesLandmark
 
Presentation for umass workshop final 2
Presentation for umass workshop final 2Presentation for umass workshop final 2
Presentation for umass workshop final 2nanalaw
 
Resposbility of regulatory affairs professional
Resposbility of regulatory affairs professional Resposbility of regulatory affairs professional
Resposbility of regulatory affairs professional DewyangiChudasama
 
Expediting drug-biologics-development-chapter3(v11-final)
Expediting drug-biologics-development-chapter3(v11-final)Expediting drug-biologics-development-chapter3(v11-final)
Expediting drug-biologics-development-chapter3(v11-final)luismanolo09
 
Abpi launched clinical trial disclosure toolkit
Abpi launched clinical trial disclosure toolkitAbpi launched clinical trial disclosure toolkit
Abpi launched clinical trial disclosure toolkitsushant deshmukh
 
Abpi launched clinical-trial_disclosure_toolkit
Abpi launched clinical-trial_disclosure_toolkitAbpi launched clinical-trial_disclosure_toolkit
Abpi launched clinical-trial_disclosure_toolkitsushant deshmukh
 
ALP_AMD without recording file
ALP_AMD without recording fileALP_AMD without recording file
ALP_AMD without recording fileHONGRAK KIM
 
Regulatory Reform - Are we heading in the right direction?
Regulatory Reform - Are we heading in the right direction?Regulatory Reform - Are we heading in the right direction?
Regulatory Reform - Are we heading in the right direction?TGA Australia
 
Operational research
Operational researchOperational research
Operational researchvysakh ts
 
v25n1a10-project-management-in-medical-publication-writing
v25n1a10-project-management-in-medical-publication-writingv25n1a10-project-management-in-medical-publication-writing
v25n1a10-project-management-in-medical-publication-writingPrashant Auti
 
Health management
Health managementHealth management
Health managementNida Naeem
 
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...Medpace
 
Technology Imperative Final
Technology Imperative  FinalTechnology Imperative  Final
Technology Imperative FinalMatthew DeFranco
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory AffairsNamdeo Shinde
 
Prescription Medicines MMDR Reforms
Prescription Medicines MMDR ReformsPrescription Medicines MMDR Reforms
Prescription Medicines MMDR ReformsTGA Australia
 
Global Regulatory Pathways for COVID-19 Therapies and Vaccines
Global Regulatory Pathways for COVID-19 Therapies and VaccinesGlobal Regulatory Pathways for COVID-19 Therapies and Vaccines
Global Regulatory Pathways for COVID-19 Therapies and VaccinesMridula Shukla
 

Similar to Project management (20)

Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...
Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...
Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...
 
Presentation for UMass Workshop
Presentation for UMass WorkshopPresentation for UMass Workshop
Presentation for UMass Workshop
 
Critical Path Initiative Challenges
Critical  Path  Initiative  ChallengesCritical  Path  Initiative  Challenges
Critical Path Initiative Challenges
 
Presentation for umass workshop final 2
Presentation for umass workshop final 2Presentation for umass workshop final 2
Presentation for umass workshop final 2
 
Resposbility of regulatory affairs professional
Resposbility of regulatory affairs professional Resposbility of regulatory affairs professional
Resposbility of regulatory affairs professional
 
Expediting drug-biologics-development-chapter3(v11-final)
Expediting drug-biologics-development-chapter3(v11-final)Expediting drug-biologics-development-chapter3(v11-final)
Expediting drug-biologics-development-chapter3(v11-final)
 
Abpi launched clinical trial disclosure toolkit
Abpi launched clinical trial disclosure toolkitAbpi launched clinical trial disclosure toolkit
Abpi launched clinical trial disclosure toolkit
 
Abpi launched clinical-trial_disclosure_toolkit
Abpi launched clinical-trial_disclosure_toolkitAbpi launched clinical-trial_disclosure_toolkit
Abpi launched clinical-trial_disclosure_toolkit
 
ALP_AMD without recording file
ALP_AMD without recording fileALP_AMD without recording file
ALP_AMD without recording file
 
Regulatory Reform - Are we heading in the right direction?
Regulatory Reform - Are we heading in the right direction?Regulatory Reform - Are we heading in the right direction?
Regulatory Reform - Are we heading in the right direction?
 
Operational research
Operational researchOperational research
Operational research
 
v25n1a10-project-management-in-medical-publication-writing
v25n1a10-project-management-in-medical-publication-writingv25n1a10-project-management-in-medical-publication-writing
v25n1a10-project-management-in-medical-publication-writing
 
EPDB - Exploratory Product Development Breif
EPDB - Exploratory Product Development BreifEPDB - Exploratory Product Development Breif
EPDB - Exploratory Product Development Breif
 
Health management
Health managementHealth management
Health management
 
PMC7
PMC7PMC7
PMC7
 
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
 
Technology Imperative Final
Technology Imperative  FinalTechnology Imperative  Final
Technology Imperative Final
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
 
Prescription Medicines MMDR Reforms
Prescription Medicines MMDR ReformsPrescription Medicines MMDR Reforms
Prescription Medicines MMDR Reforms
 
Global Regulatory Pathways for COVID-19 Therapies and Vaccines
Global Regulatory Pathways for COVID-19 Therapies and VaccinesGlobal Regulatory Pathways for COVID-19 Therapies and Vaccines
Global Regulatory Pathways for COVID-19 Therapies and Vaccines
 

Recently uploaded

BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,noida100girls
 
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...lizamodels9
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesKeppelCorporation
 
/:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In...
/:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In.../:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In...
/:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In...lizamodels9
 
Kenya’s Coconut Value Chain by Gatsby Africa
Kenya’s Coconut Value Chain by Gatsby AfricaKenya’s Coconut Value Chain by Gatsby Africa
Kenya’s Coconut Value Chain by Gatsby Africaictsugar
 
Marketplace and Quality Assurance Presentation - Vincent Chirchir
Marketplace and Quality Assurance Presentation - Vincent ChirchirMarketplace and Quality Assurance Presentation - Vincent Chirchir
Marketplace and Quality Assurance Presentation - Vincent Chirchirictsugar
 
Future Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted VersionFuture Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted VersionMintel Group
 
Market Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMarket Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMintel Group
 
India Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample ReportIndia Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample ReportMintel Group
 
Call Girls In Connaught Place Delhi ❤️88604**77959_Russian 100% Genuine Escor...
Call Girls In Connaught Place Delhi ❤️88604**77959_Russian 100% Genuine Escor...Call Girls In Connaught Place Delhi ❤️88604**77959_Russian 100% Genuine Escor...
Call Girls In Connaught Place Delhi ❤️88604**77959_Russian 100% Genuine Escor...lizamodels9
 
Investment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy CheruiyotInvestment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy Cheruiyotictsugar
 
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / NcrCall Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncrdollysharma2066
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCRashishs7044
 
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607dollysharma2066
 
Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Riya Pathan
 
Kenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith PereraKenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith Pereraictsugar
 
Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Kirill Klimov
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCRashishs7044
 
Intro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdfIntro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdfpollardmorgan
 
2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis Usage2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis UsageNeil Kimberley
 

Recently uploaded (20)

BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
 
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation Slides
 
/:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In...
/:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In.../:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In...
/:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In...
 
Kenya’s Coconut Value Chain by Gatsby Africa
Kenya’s Coconut Value Chain by Gatsby AfricaKenya’s Coconut Value Chain by Gatsby Africa
Kenya’s Coconut Value Chain by Gatsby Africa
 
Marketplace and Quality Assurance Presentation - Vincent Chirchir
Marketplace and Quality Assurance Presentation - Vincent ChirchirMarketplace and Quality Assurance Presentation - Vincent Chirchir
Marketplace and Quality Assurance Presentation - Vincent Chirchir
 
Future Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted VersionFuture Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted Version
 
Market Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMarket Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 Edition
 
India Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample ReportIndia Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample Report
 
Call Girls In Connaught Place Delhi ❤️88604**77959_Russian 100% Genuine Escor...
Call Girls In Connaught Place Delhi ❤️88604**77959_Russian 100% Genuine Escor...Call Girls In Connaught Place Delhi ❤️88604**77959_Russian 100% Genuine Escor...
Call Girls In Connaught Place Delhi ❤️88604**77959_Russian 100% Genuine Escor...
 
Investment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy CheruiyotInvestment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy Cheruiyot
 
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / NcrCall Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
 
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
 
Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737
 
Kenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith PereraKenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith Perera
 
Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
 
Intro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdfIntro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdf
 
2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis Usage2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis Usage
 

Project management

  • 1. PROJECT MANAGEMENT IN PHARMACEUTICAL INDUSTRY Prepared By: Guided By: Chandani Tripathi Dr. Gayatri Patel 17MPHRA010 Associate Professor 1
  • 2. 2
  • 3. Table of Content • INTRODUCTION • WHAT IS PLANNING? • WHY PLANNING? • TYPES OF PLANNING • STEPS INVOLVED IN PLANNING • ELEMENTS OF PLANNING • CHALLENGES 3
  • 4. • CONTROL AND IMPLEMENTATION • PRE-REQUISITES FOR SUCCESSFUL PROJECT IMPLEMENTATION • HOW DOES ONE MEASURES PROJECT SUCCESS • CASE STUDY • SUMMARY • REFERENCES 4
  • 5. INTRODUCTION • Regulatory policies and compliances -----for new drug -------tighter, impacting product development, and registration strategies. • The pharmaceutical industry is under pressure to accelerate the drug- development stage to compensate for the longer wait for regulatory approval. As a result the companies are working on new products in parallel- -----this leads to further hurdles in management of the product at once. • Wourms B. Pharmaceutical Organizations Discover New Way to Stay Ahead of the Game: Project Management Outsourc. Pharm Process [Internet]. 2003;(16–18). 5
  • 7. WHAT IS PLANNING? • Analyzing the current situation • Assessing needs • Establishing goals • Setting objectives & targets • Determining the strategies & responsibilities • Resources • Pharmaceutical Project Management- Tony Kennedy. Published by Marcel Dekkar, inc., New York Pg no. 57-64. 7
  • 8. Why should one go for planning? To clearly identify goals To assess current needs and problems To ensure wise use of available human and financial resources To obtain additional resources To provide a basis for evaluating effectiveness To align staff priorities and build a sense of teamwork Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15. 8
  • 9. What are the types of planning ? WORK PLANNING Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15. 9
  • 10. Process Program planning Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15. 10
  • 11. QA Dept. Pharmaceutical Management-Sachin Itkar. Published by Nirali Prakashan Pg no. 3.1-3.2 & 15.1-15.7 11
  • 12. Warehouse Dept. Pharmaceutical Management-Sachin Itkar. Published by Nirali Prakashan Pg no. 3.1-3.2 & 15.1-15.7 12
  • 13. Pharmaceutical Management-Sachin Itkar. Published by Nirali Prakashan Pg no. 3.1-3.2 & 15.1-15.7 13
  • 14. Supply chain Management Pharmaceutical Management-Sachin Itkar. Published by Nirali Prakashan Pg no. 3.1-3.2 & 15.1-15.7 14
  • 15. Steps Involvedin Planning the Process Define the target. Prepare a list of necessary work packages (studies). Determine the logical sequence and estimate durations. Determine the critical path. 15
  • 16. Steps Involvedin Planning the Process Optimize the plan to reduce critical path length. Plan resources and costs and adjust for resource and budget constraints and priorities. Adjust plan during execution to new data, as required. Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15. 16
  • 19. Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15. 19
  • 20. PROJECT IMPLEMENTATION Adequate Formulation Proper implementation planning Advance action Timely availability of funds Judicious equipment tendering and procurement Better contract management Effective monitoring mds3-ch38-planningmgmt-mar2012. 20
  • 21. 21
  • 23. Portfolio P, Systems M. Project Portfolio Management in the Pharmaceutical Industry Do Pharmaceutical Companies benefit financially from Project Portfolio Management Systems ? Fjóla Steingrímsdóttir Project Portfolio Management in the Pharmaceutical Industry. 23
  • 24. 24
  • 25. Eli Lilly Background: Founded in 1876 in Indianapolis, USA, by Colonel Eli Lilly. • 1st to produce insulin in 1923 + human insulin using recombinant DNA. • Lilly is also the world's largest manufacturer and distributor of psychiatric medications. • 9th world's biggest pharmaceutical company. • Crisis/ Problem: The patent expiration for Prozac as it counts 20 % of the company's overall revenue.------ drop in sales by 23% . • Raja BH. Open Innovation in Pharmaceutical Industry : A case study of Eli Lilly Open Innovation in Pharmaceutical Industry : A case study of Eli Lilly. 2015; 25
  • 26. • 2) Fine imposed for illegal marketing. (Zyprexa) • 3) Distrust that turned out in more restriction for drug approvals. SOLUTION: 1) Increase in R&D budget by 30%, ($2.2 billion), hiring 700 scientists. 2) The firm extended their areas from psychopharmacology to a larger fields like Neuroscience, Oncology, Endocrinology, Cardiovascular etc. 3) The Office of Alliance Management, based on the idea of (I) Find it, (II) Get it, (III) Create value. 26
  • 27. 27
  • 28. 28
  • 29. • TBDDI is Lilly’s Tuberculosis drug discovery • TB Drug Accelerator (TBDA) • Open innovation drug discovery program • Public-Private partnerships (PPP) Result: Due to these collaborations and technology transfer/ Knowledge exchange the company has successfully regained its lost position. The new upcoming tools like Crowdsourcing and open source drug discovery being implemented by these company make the Outsource Licensing initiatives multilateral all over the world making the innovation network boundary more porous. Raja BH. Open Innovation in Pharmaceutical Industry : A case study of Eli Lilly Open Innovation in Pharmaceutical Industry : A case study of Eli Lilly. 2015; 29
  • 30. References Pharmaceutical Project Management- Tony Kennedy. Published by Marcel Dekkar, inc., New York Pg no. 57-64. Projects-Prasanna Chandra. Published by McGraw Hill Education (India) Private Limited, Pg no. 21.9-21.15. Pharmaceutical Management-Sachin Itkar. Published by Nirali Prakashan Pg no. 3.1-3.2 & 15.1-15.7 Portfolio P, Systems M. Project Portfolio Management in the Pharmaceutical Industry Do Pharmaceutical Companies benefit financially from Project Portfolio Management Systems ? Fjóla Steingrímsdóttir Project Portfolio Management in the Pharmaceutical Industry. mds3-ch38-planningmgmt-mar2012. 30
  • 31. 31